Stocks
Neurotrope (NTRP) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 153 345% | 87 091% | 117.6% | 247.5% | 167.9% | 161.3% | |||
| Changes by years, y/y, % | +20 473pp | -66 253pp | -86 974pp | +130pp | -80pp | -73.7% | |||
Neurotrope. R&D/CAPEX, %
Neurotrope. R&D/CAPEX, changes, pp
Neurotrope (NTRP) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2020Q3 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| R&D/CAPEX, % | 163.3% | 265.7% | 183.3% | 0.61% | 161.3% | |||
| Changes by years, y/y, % | ||||||||
| Changes by quarters, q/q, % | -15 580pp | +102pp | -82pp | -183pp | ||||
